
New HEAL Research Priorities Article: Prioritize clinical and community-embedded research, hybrid implementation-effectiveness studies, and pragmatic trials for real-world impact, scalability, and sustainability
Translating efficacious pain interventions into sustainable clinical practice requires a fundamental methodological shift. The latest article in the HEAL Research Priorities series explores Priority H, emphasizing the critical need for clinical and community embedded research, hybrid implementation effectiveness studies, and pragmatic trials.
In this new interview, Stephani Sutherland speaks with implementation science experts Lynn DeBar, PhD, MPH, and Steven Z. George, PT, PhD, FAPTA, about the translational gap between controlled efficacy and complex healthcare environments.
Key topics include:
-
The methodological advantages of hybrid trials that coprioritize effectiveness and implementation outcomes.
-
Coupling the implementation of high value interventions with the strategic deimplementation of low value care.
-
Aligning research metrics with the priorities of diverse stakeholders, including healthcare systems, payors, and patients.
-
Developing and evaluating integrated pathways of care to reduce health disparities.
Read the full interview to explore the future of translational pain research, and join the discussion in the PURPOSE forum to share your perspectives on navigating implementation methodologies.
